The overall survival of PC patients with high ICAM1 expression was significantly worse than those with low ICAM1 expression (Figure 1H, p = 0.021, log–rank test), suggesting that ICAM1 may also serve as a clinical biomarker of poor prognosis in PC patients. The gene discussed is ICAM1; the disease is pachyonychia congenita.